JPMorgan Chase & Co. Has $30.50 Million Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

JPMorgan Chase & Co. increased its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 107.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 459,464 shares of the company's stock after acquiring an additional 238,064 shares during the quarter. JPMorgan Chase & Co. owned about 0.18% of Ryan Specialty worth $30,504,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Hollencrest Capital Management purchased a new position in Ryan Specialty during the third quarter valued at $25,000. Assetmark Inc. bought a new position in shares of Ryan Specialty during the 3rd quarter valued at about $34,000. Quarry LP grew its position in shares of Ryan Specialty by 109.3% during the third quarter. Quarry LP now owns 808 shares of the company's stock valued at $54,000 after purchasing an additional 422 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Ryan Specialty by 106.4% in the third quarter. GAMMA Investing LLC now owns 1,249 shares of the company's stock worth $83,000 after purchasing an additional 644 shares during the last quarter. Finally, Signaturefd LLC lifted its position in shares of Ryan Specialty by 12.3% in the third quarter. Signaturefd LLC now owns 1,347 shares of the company's stock worth $89,000 after buying an additional 148 shares in the last quarter. 84.82% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several brokerages have weighed in on RYAN. Morgan Stanley started coverage on Ryan Specialty in a research note on Thursday, December 5th. They set an "overweight" rating and a $90.00 price objective on the stock. Bank of America boosted their target price on Ryan Specialty from $75.00 to $84.00 and gave the company a "buy" rating in a research report on Thursday, October 10th. The Goldman Sachs Group raised their price target on Ryan Specialty from $64.00 to $72.00 and gave the stock a "neutral" rating in a research report on Wednesday, October 9th. Wells Fargo & Company boosted their price objective on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an "equal weight" rating in a research report on Thursday, October 10th. Finally, Barclays raised their target price on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an "overweight" rating in a report on Thursday, November 21st. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $73.50.

Insider Transactions at Ryan Specialty

In other news, Director David P. Bolger sold 7,055 shares of the business's stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $70.88, for a total transaction of $500,058.40. Following the transaction, the director now directly owns 78,149 shares in the company, valued at $5,539,201.12. The trade was a 8.28 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Mark Stephen Katz sold 14,790 shares of the company's stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $71.39, for a total value of $1,055,858.10. Following the completion of the transaction, the executive vice president now directly owns 12,386 shares in the company, valued at approximately $884,236.54. The trade was a 54.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 126,936 shares of company stock valued at $8,536,282 in the last quarter. Insiders own 11.10% of the company's stock.

Ryan Specialty Trading Up 0.6 %

NYSE RYAN traded up $0.37 during trading hours on Wednesday, hitting $61.11. 1,267,611 shares of the company's stock were exchanged, compared to its average volume of 951,862. The firm has a market capitalization of $16.00 billion, a P/E ratio of 79.36, a price-to-earnings-growth ratio of 1.52 and a beta of 0.72. Ryan Specialty Holdings, Inc. has a 12-month low of $41.65 and a 12-month high of $75.97. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The business's 50 day moving average is $68.64 and its 200-day moving average is $65.64.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share for the quarter, meeting the consensus estimate of $0.41. The business had revenue of $604.69 million for the quarter, compared to analyst estimates of $602.04 million. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The business's quarterly revenue was up 20.5% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.32 EPS. As a group, analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, November 12th. This represents a $0.44 annualized dividend and a dividend yield of 0.72%. Ryan Specialty's dividend payout ratio (DPR) is 57.14%.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.